AMCP-Opposed Biosimilars Bill Vetoed by Gov. Brown

Consumers Assured of Greater Access to Lower-Cost Therapy Options 

For Immediate Release

Alexandria, Va., October 14, 2013 — The Academy of Managed Care Pharmacy (AMCP) today issued a statement in response to California Gov. Edmund G. Brown, Jr.’s veto of Senate Bill 598, which would have created a separate state system for dispensing biosimilar products before the federal government completed its review of biosimilars and implemented a national policy. In September AMCP wrote Gov. Brown urging him to veto the bill and called on its 1,000 California members to contact the governor’s office.
The statement of AMCP CEO Edith A. Rosato, RPh, IOM, follows:
This past Saturday California Gov. Edmund G. Brown, Jr. put consumers first by vetoing Senate Bill 598. As California is the nation’s largest state, his veto avoids setting a precedent that could have had nationwide implications for patients, providers and payers.
Had SB 598 become law, it would have dramatically reduced prescription drug options for patients and their doctors in the nation’s largest state. The governor’s veto wisely preserves both access to safe, effective and lower-cost medications and the right of patients to choose the most appropriate medicines. It means pharmacists won’t be subjected to new, costly and unnecessary reporting requirements for biosimilars; instead, generic drug reporting requirements will continue to apply.
It goes without saying that whenever more patients have wider access to lower-cost, effective therapies, our nation’s goal of increasing access to affordable health care is being achieved. But it bears repeating because legislation like SB 598 would have taken the nation’s largest state in the opposite direction.
To read AMCP's letter to Gov. Brown, click here
About AMCP  
The Academy of Managed Care Pharmacy is a national professional association of pharmacists and other health care practitioners who serve society by the application of sound medication management principles and strategies to improve health care for all. The Academy's nearly 7,000 members develop and provide a diversified range of clinical, educational and business management services and strategies on behalf of the more than 200 million Americans covered by a managed care pharmacy benefit. It is celebrating its 25th anniversary in 2013. More news and information about the Academy can be found at 
For more information, please contact:
Kevin Bruns | 703-683-8416 ext. 656